Abstract
Adjuvant chemotherapy completes the local treatment of breast cancer and aims at reducing recurrences and improving the survival rate of high risk patients. As its present benefits mainly apply to the free interval and to some categories of subjects, further controlled study is required to assess its value.
Publication types
-
Clinical Trial
-
English Abstract
-
Review
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Breast Neoplasms / drug therapy*
-
Breast Neoplasms / therapy
-
Clinical Trials as Topic
-
Combined Modality Therapy
-
Female
-
Humans
-
Lymphatic Metastasis
-
Menopause
-
Prognosis
-
Risk
-
Time Factors